drugset / Trial / NCT05672212

Goal-directed Analgesia Using ANI During General Anesthesia in Children With Moyamoya Disease

NCT05672212 ↗

RandomizedParallel-groupOpen-labelOther

Summary

Analgesia Nociception Index (ANI) has been proposed for the evaluation of the nociception-antinociception balance in the perioperative period. In pediatric patients with Moyamoay disease, where the management of analgesia may be rendered difficult by pharmacological changes, we hypothesised that the monitoring of analgesia with ANI would reduce intraoperative opioid consumption during EDAS surgery.

Timeline

Start
2023-01-04
Primary completion
2025-01-04
Completion
2025-01-04

Outcome

Met primary endpoint

paper The Analgesia Nociception Index group showed lower intra-operative sufentanil consumption PMID 38832435 ↗

paper mean difference, -0.09; 95% confidence interval, -0.19 to 0.00; P  = 0.049 PMID 38832435 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Sufentanil Other / unclassified — Other

Indications

No indication recorded.